$27.02
+0.45
(+1.69%)▲
3.44%
Downside
Day's Volatility :4.64%
Upside
1.24%
23.24%
Downside
52 Weeks Volatility :29.6%
Upside
8.28%
Period | Upstream Bio Inc. | Index (Russel 2000) |
---|---|---|
3 Months | 22.82% | 0.0% |
6 Months | 22.82% | 0.0% |
1 Year | 22.82% | 0.0% |
3 Years | 22.82% | -27.6% |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | 0.0% |
Return On Equity TTM | 0.0% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
Diluted Eps TTM | 0.0 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
Sell
Neutral
Buy
Upstream Bio Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Upstream Bio Inc. | 22.82% | 22.82% | 22.82% | 22.82% | 22.82% |
Regeneron Pharmaceuticals, Inc. | -17.98% | -13.74% | 0.21% | 32.39% | 141.22% |
Biontech Se | -10.32% | 19.69% | 8.29% | -55.53% | 471.7% |
Alnylam Pharmaceuticals, Inc. | 0.38% | 78.75% | 60.7% | 44.82% | 192.62% |
Vertex Pharmaceuticals Incorporated | 9.48% | 19.97% | 33.29% | 161.38% | 149.59% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Upstream Bio Inc. | NA | NA | NA | 0.0 | 0.0 | 0.0 | NA | NA |
Regeneron Pharmaceuticals, Inc. | 20.53 | 20.53 | 1.2 | 44.89 | 0.17 | 0.07 | NA | 272.04 |
Biontech Se | 160.8 | NA | 0.04 | -3.11 | -0.02 | -0.01 | NA | 79.73 |
Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -1.87 | -15.01 | -0.03 | NA | 0.25 |
Vertex Pharmaceuticals Incorporated | 32.84 | NA | 1.27 | 0.19 | -0.03 | 0.13 | NA | 60.66 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Upstream Bio Inc. | NA | NA | 22.82% | NA | 0.0% |
Regeneron Pharmaceuticals, Inc. | Buy | $91.1B | 141.22% | 20.53 | 33.61% |
Biontech Se | Buy | $25.6B | 471.7% | 160.8 | -15.36% |
Alnylam Pharmaceuticals, Inc. | Buy | $35.2B | 192.62% | NA | -15.86% |
Vertex Pharmaceuticals Incorporated | Buy | $128.9B | 149.59% | 32.84 | -4.51% |
Organization | Upstream Bio Inc. |
Industry | Miscellaneous |
Cactus Acquisition Corp 1 Ltd
$27.02
+1.69%
Rigel Resource Acquisition Corp
$27.02
+1.69%
Bj's Restaurants
$27.02
+1.69%
John Hancock Income Securities Closed Fund
$27.02
+1.69%
United Homes Group Inc
$27.02
+1.69%
Quantum Fintech Acquisition Corp
$27.02
+1.69%
Invesco Wilderhill Clean Energy Etf
$27.02
+1.69%
Harte Hanks Inc
$27.02
+1.69%
Clearbridge Dividend Strategy Esg Etf
$27.02
+1.69%